EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY-NC 4.0

Silencing genes in the vaginal mucosa by topical application of a cholesterol‐modified siRNA to inhibit HIV transmission

Merilyn H Hibma

Journal of the European Academy of Dermatology and Venereology · 2023

DOI: 10.1111/jdv.18877 ↗

Kurz gefasst

Kommentar in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2023. Verfasst von Merilyn H Hibma. Beteiligte Einrichtung: Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Vagina, HIV Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VaginaHIV InfectionsFemaleHumansRNA, Small InterferingMucous MembraneCholesterol

Substanzen

RNA, Small InterferingCholesterol

Autor:innen und Institutionen

  • Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.

Zitieren

APA

Hibma, M. H. (2023). Silencing genes in the vaginal mucosa by topical application of a cholesterol‐modified siRNA to inhibit HIV transmission. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.18877

Vancouver

Hibma MH. Silencing genes in the vaginal mucosa by topical application of a cholesterol‐modified siRNA to inhibit HIV transmission. Journal of the European Academy of Dermatology and Venereology. 2023. doi:10.1111/jdv.18877

BibTeX
@article{Hibma2023,
  author = {Hibma, Merilyn H},
  title = {Silencing genes in the vaginal mucosa by topical application of a cholesterol‐modified siRNA to inhibit HIV transmission},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2023},
  doi = {10.1111/jdv.18877}
}
Kostenlos starten →